Diabetes continues to be one of humanity’s greatest challenges. According to the World Health Organization, diabetes was directly responsible for 1.5 million fatalities in 2019. Abbott Laboratories, Tandem Diabetes Care, Johnson & Johnson, and Medtronic are among the most popular diabetes care companies among investors in 2021. Diabetes continues to be one of the world’s fastest-growing chronic diseases. Diabetes affected 11% of the US population, or 34.2 million people, in 2018. In 2020, the worldwide diabetes care device sector was worth $49 billion, and by 2026, it is expected to be worth $69 billion.
Insider Monkey takes a look at the 10 best diabetes stocks to buy now. The Danish pharmaceutical company Novo Nordisk A/S pioneered essential insulin manufacture in 1923. Rybelsus, the first oral tablet to regulate blood sugar in adult patients with type 2 diabetes, was created by the business. With a yield of 1.41 percent, it is a safe option for income investors. On October 14, the FDA accepted Novartis AG’s supplemental Biologics License Application (sBLA) for its diabetic macular edema oral medication Beovu, with regulatory decisions expected in Europe and the United States in mid-2022. Tandem Diabetic Care, Inc., a maker of insulin pumps, is ranked eighth on the list of the top ten diabetes stocks to purchase right now. The company’s revenue increased 58 percent year over year to $172.1 million in the second quarter. AstraZeneca PLC is one of the world’s largest vaccine manufacturers. The pharmaceutical business is ranked seventh in the list of the top ten diabetes stocks to purchase right now. In the second quarter of 2021, AstraZeneca reported a 31 percent increase in global sales to $8.22 billion. Insulet Corporation is a global provider of insulin delivery systems. Insulet’s revenue increased 16.3 percent year over year to $263.2 million in the second quarter, owing to strong demand for its Omnipod products. For more details, click 10 Best Diabetes Stocks To Buy Now.
Pixabay
